(Q34468887)

2 August 2017

title

An economic overview of prostate carcinoma (English)

1 reference

2 August 2017

Ruchlin HS

1

1 reference

2 August 2017

Pellissier JM

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

92

1 reference

2 August 2017

issue

11

1 reference

2 August 2017

page(s)

2796-2810

1 reference

2 August 2017

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

The relation between funding by the National Institutes of Health and the burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

The cost of prostatic cancer in a defined population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Geographic variation in the treatment of prostate cancer in Connecticut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Cost-effectiveness comparison of estrogen therapy and orchidectomy in patients with prostatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Physician resource utilization in radiation oncology: a model based on management of carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Cost-effectiveness of androgen suppression therapies in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

The sensitivity of Medicare claims data for case ascertainment of six common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Validity of self-reported diagnoses leading to hospitalization: a comparison of self-reports with hospital records in a prospective study of American adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

The dilemma of prostate cancer--a growing human and economic burden irrespective of treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Why do sicker patients cost more? A charge-based analysis of patients undergoing prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Patterns of care related to age of men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Factors that determine the treatment for local and regional prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Effects of health insurance and race on early detection of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

How expert physicians would wish to be treated if they had genitourinary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

The burden of prostate cancer from diagnosis until death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Advanced prostate cancer: course, care, and cost implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

HMO membership, treatment, and mortality risk among prostatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Comparison of the hospital costs for radical prostatectomy and cryosurgical ablation of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

A comparison of the cost of various treatment methods for early cancer of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Cost benefit of emerging technology in localized carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

A clinical-care pathway for decreasing hospital stay after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Early hospital discharge after radical retropubic prostatectomy: impact on cost and complication rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Mini-laparotomy pelvic lymph node dissection minimizes morbidity, hospitalization and cost of pelvic lymph node dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Comparative financial analysis of laparoscopic versus open pelvic lymph node dissection for men with cancer of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

A retrospective analysis of the cost effectiveness of treatment with Metastron (89Sr-chloride) in patients with prostate cancer metastatic to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

The cost effectiveness of 3D conformal radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Impact on health service costs of medical technologies used in management of prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

CT screening for comorbid disease in patients with prostatic carcinoma: is it cost-effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

Population-based study of relationships between hospital volume of prostatectomies, patient outcomes, and length of hospital stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2796%3A%3AAID-CNCR10124%3E3.0.CO%3B2-R

10.1002/1097-0142(20011201)92:11<2796::AID-CNCR10124>3.0.CO;2-R

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference